Trivarx Ltd has released a press release.
December 2024 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- TrivarX Receives $1.03m R&D Tax Incentive
- New AI Tool Expands Patient Reach and Market Opportunities
- September 2024 Quarterly Activities Report and Appendix 4C
- June 2024 Quarterly Activities Report and Appendix 4C
- Positive Results from Phase 2 SAMDE Study
Later from TrivarX
- Appendix 4D & Half-Year Financial Report to 31 December 2024
- Trial with US Department of Veterans Affairs
- TrivarX Receives Firm Commitments to Raise $2.25 million
- IRB approval for trial with US Dept of Veterans Affairs
- March 2025 Quarterly Activities Report and Appendix 4C
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX